Yu. M. Kotsur
Yu. M. Kotsur has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Elena Flisyuk
Department of Pharmaceutical Formulations, St. Petersburg State Chemical Pharmaceutical University, 14a Prof. Popov Str., 197022 Saint-Petersburg, Russia
17 shared publications Ю. М. Коцур
Федеральное государственное бюджетное образовательное учреждение высшего образования «Санкт-Петербургский государственный химико-фармацевтический университет» Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФУ Минздрава России)
13 shared publications- Igor Anatolyevich Narkevich
Saint Petersburg State Chemical-Pharmaceutical University
11 shared publications - Irina A. Titovich
Saint Petersburg State Chemical and Pharmaceutical University (SPCPU)
5 shared publications - Irina E. Smekhova
Saint-Petersburg State Chemical and Pharmaceutical University
4 shared publications - S. D. Malkov
Saint-Petersburg State Chemical and Pharmaceutical University
4 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
An investigation into the effect of polymer components on the physicochemical and mechanical properties of hemostatic sponges
Introduction. Sponges are the most widely used form of topical hemostatic agents. Regulatory requirements for sponges are often incomplete and do not cover some properties, especially at the pharmaceutical development stage. Aim. To evaluate the effect of polymers on the properties of hemostatic sponges. Materials and methods. The study used sodium carboxymethylcellulose (Na-CMC), sodium alginate, polyethylene glycol (PEG-6000), and a copolymer of methacrylic acid and ethyl acrylate (CMAEA). Samples were prepared by freeze-drying and evaluated for appearance, density, porosity, absorption capacity, swelling ratio, and swelling kinetics. Data normalization was performed to compare the results. Results and discussion. The appearance of the samples depended on the starting component. An increase in component concentration led to higher sponge density. Maximum porosity was observed in compositions containing 3 % PEG-6000 or CMAEA. The matrix-forming components showed similar absorption capacity, while the addition of synthetic polymers reduced this parameter. The swelling ratio decreased in the order Na-CMC > sodium alginate > PEG-6000/CMAEA, and the composition with 1 % Na-CMC showed the maximum swelling ratio. Conclusion. The effect of sponge components on appearance, density, porosity, absorption capacity, swelling ratio, and swelling kinetics was considered. The nature of the effect of individual components on specific physicochemical and mechanical properties of the sponges was determined. The results can be used to justify the choice of excipients in the development of hemostatic sponges.
- 23 October 2026
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
Open AccessAn investigation into the effect of polymer components on the physicochemical and mechanical properties of hemostatic sponges
Introduction. Sponges are the most widely used form of topical hemostatic agents. Regulatory requirements for sponges are often incomplete and do not cover some properties, especially at the pharmaceutical development stage. Aim. To evaluate the effect of polymers on the properties of hemostatic sponges. Materials and methods. The study used sodium carboxymethylcellulose (Na-CMC), sodium alginate, polyethylene glycol (PEG-6000), and a copolymer of methacrylic acid and ethyl acrylate (CMAEA). Samples were prepared by freeze-drying and evaluated for appearance, density, porosity, absorption capacity, swelling ratio, and swelling kinetics. Data normalization was performed to compare the results. Results and discussion. The appearance of the samples depended on the starting component. An increase in component concentration led to higher sponge density. Maximum porosity was observed in compositions containing 3 % PEG-6000 or CMAEA. The matrix-forming components showed similar absorption capacity, while the addition of synthetic polymers reduced this parameter. The swelling ratio decreased in the order Na-CMC > sodium alginate > PEG-6000/CMAEA, and the composition with 1 % Na-CMC showed the maximum swelling ratio. Conclusion. The effect of sponge components on appearance, density, porosity, absorption capacity, swelling ratio, and swelling kinetics was considered. The nature of the effect of individual components on specific physicochemical and mechanical properties of the sponges was determined. The results can be used to justify the choice of excipients in the development of hemostatic sponges.
- Open Access
- 2 March 2026
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 15 (1) , 53-61
Application of the quality by design (QbD) approach for the development of composition of extended-release tablets based on sodium 4,4’-(propanediamido)dibenzoate
Introduction. Pharmaceutical development is a complex work, the main goal of which is to achieve the quality target product profile (QTPP). QTPP is formulated on the basis of a whole set of requirements for the drug, including pharmacopoeial, consumer, pharmacological, etc. The traditional empirical approach to the development of the composition and technology of the dosage form in this case seems to be labor and resource-intensive, while it does not fully achieve an understanding of all processes both from the point of view of technology and from the point of view of further stages of the life cycle of the drug. The Quality by Design (QbD) approach allows you to assess the impact of factors on processes, which, in turn, contributes to proactive risk management and the creation of robust technologies. Aim. Demonstrate the comprehensive use of QbD tools, including expert systems (Sediment Delivery Model, SeDeM), experimental planning (Design of Experiment, DoE) and risk analysis, using the example of the development of prolonged-release tablets based on sodium 4,4’-(propanediamido)dibenzoate. Materials and methods. The paper uses the original active pharmaceutical ingredient (API) – sodium 4,4’-(propanediamido) dibenzoate, modern excipients and polymers that provide prolonged release (ethylcellulose, hydroxypropyl methylcellulose, etc.). At the first stage, the SeDeM method was used to design the compositions. In the second step, screening DoE was used to optimize the release profile Results and discussion. The SeDeM method made it possible to quantify and neutralize the risks associated with the unsatisfactory technological properties of the API. Compositions with satisfactory technological properties were designed and experimentally confirmed. As a result of DoE, it was found that HPMC provides the most complete and uniform release (more than 80% in 12 hours), close to zero-order release kinetics. Conclusion. The comprehensive use of QbD tools made it possible to effectively and reasonably develop a robust composition of prolonged-release tablets based on sodium 4,4’-(propanediamido) dibenzoate, providing both the required technological properties and the required release profile.
- 2 March 2026
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 15 (1) , 53-61
Open AccessApplication of the quality by design (QbD) approach for the development of composition of extended-release tablets based on sodium 4,4’-(propanediamido)dibenzoate
Introduction. Pharmaceutical development is a complex work, the main goal of which is to achieve the quality target product profile (QTPP). QTPP is formulated on the basis of a whole set of requirements for the drug, including pharmacopoeial, consumer, pharmacological, etc. The traditional empirical approach to the development of the composition and technology of the dosage form in this case seems to be labor and resource-intensive, while it does not fully achieve an understanding of all processes both from the point of view of technology and from the point of view of further stages of the life cycle of the drug. The Quality by Design (QbD) approach allows you to assess the impact of factors on processes, which, in turn, contributes to proactive risk management and the creation of robust technologies. Aim. Demonstrate the comprehensive use of QbD tools, including expert systems (Sediment Delivery Model, SeDeM), experimental planning (Design of Experiment, DoE) and risk analysis, using the example of the development of prolonged-release tablets based on sodium 4,4’-(propanediamido)dibenzoate. Materials and methods. The paper uses the original active pharmaceutical ingredient (API) – sodium 4,4’-(propanediamido) dibenzoate, modern excipients and polymers that provide prolonged release (ethylcellulose, hydroxypropyl methylcellulose, etc.). At the first stage, the SeDeM method was used to design the compositions. In the second step, screening DoE was used to optimize the release profile Results and discussion. The SeDeM method made it possible to quantify and neutralize the risks associated with the unsatisfactory technological properties of the API. Compositions with satisfactory technological properties were designed and experimentally confirmed. As a result of DoE, it was found that HPMC provides the most complete and uniform release (more than 80% in 12 hours), close to zero-order release kinetics. Conclusion. The comprehensive use of QbD tools made it possible to effectively and reasonably develop a robust composition of prolonged-release tablets based on sodium 4,4’-(propanediamido) dibenzoate, providing both the required technological properties and the required release profile.
- Open Access
- 3 December 2025
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 14 (4) , 101-107
Optimisation of technological parameters for production of lipid nanoparticles for delivery of mRNA
Introduction. Gene therapy is actively developing through the use of mRNA agents for the treatment and prevention of various diseases. To manifest a therapeutic effect, it is necessary to deliver mRNA to target cells and induce the synthesis of target proteins. Key challenges include developing safe and efficient delivery systems. The critical quality attributes for lipid nanoparticles are average particle size, polydispersity index, and ζ potential. Aim. To study and optimize the assembly conditions of lipid nanoparticles to control their basic characteristics. Materials and methods. Ionizable lipid heptadecan-9yl(Z)-N-((4-dimethylamino)butyl)thio)carbonyl)-N-(2-(non-2-en-1-yloxy)-2-oxoethyl)glycinate (IL) and helper lipids – dipalmitoylglierophosphate (DPPC), cholesterol, and a-(3"-[1,2-di (myristyloxy) propanoxy]carbonylamino}propyl)-w-methoxypolyoxyethylene (DMG-PEG2000). Solvents: absolute alcohol, purified water. Buffer solutions: acetate buffer solution (pH 4.5), phosphate buffer solution (pH 7.4). Equipment: microfluidic installation Dolomite (Dolomite Microfluidics, Великобритания), Y-shaped polymer microfluidic chip with passive micromixer type "tesla coil", Nanosizer Zeta Pro nanoscale particle analyzer (LLC "Microtrack", Russia). Results and discussion. The study examined the effects of TFR and FRR parameters on LNF properties. Characteristics such as hydrodynamic diameter (Z-average), average particle diameter (D50), polydispersity index (PDI) and ζ potential were analyzed. The study confirms that with increasing FRR, the average hydrodynamic and median particle sizes decrease. Increasing TFR also decreases Z-average and D50 through hydrodynamic focusing, but at TFR = 3200 μl/min, particle size increases due to decreased nanoemulsion stability and fine particle aggregation. The study did not reveal a direct relationship between FRR and PDI. Nanoemulsions with FRRs of 1 : 3 and 1 : 4 showed the greatest homogeneity. As TFR increases, the polydispersity of the nanoparticles decreases. In the study, the dependence of the ζ potential of lipid nanoparticles on the estimated process parameters was not found. However, as TFR increases, the ζ potential tends to increase. Conclusion. In the study, the conditions for assembling lipid nanoparticles (LNP) using the microfluidic method were optimized. Mathematical models are proposed to control characteristics of nanoparticles. Optimal conditions for producing LNP: FRR = 1 : 3; 1 : 4; TFR 2000 to 3000 µL/min. If FRR = 1 : 5 and/or TFR > 3000 µL/min are used, the values may be outside the optimal range, which requires additional risk assessment.
- 3 December 2025
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 14 (4) , 101-107
Open AccessOptimisation of technological parameters for production of lipid nanoparticles for delivery of mRNA
Introduction. Gene therapy is actively developing through the use of mRNA agents for the treatment and prevention of various diseases. To manifest a therapeutic effect, it is necessary to deliver mRNA to target cells and induce the synthesis of target proteins. Key challenges include developing safe and efficient delivery systems. The critical quality attributes for lipid nanoparticles are average particle size, polydispersity index, and ζ potential. Aim. To study and optimize the assembly conditions of lipid nanoparticles to control their basic characteristics. Materials and methods. Ionizable lipid heptadecan-9yl(Z)-N-((4-dimethylamino)butyl)thio)carbonyl)-N-(2-(non-2-en-1-yloxy)-2-oxoethyl)glycinate (IL) and helper lipids – dipalmitoylglierophosphate (DPPC), cholesterol, and a-(3"-[1,2-di (myristyloxy) propanoxy]carbonylamino}propyl)-w-methoxypolyoxyethylene (DMG-PEG2000). Solvents: absolute alcohol, purified water. Buffer solutions: acetate buffer solution (pH 4.5), phosphate buffer solution (pH 7.4). Equipment: microfluidic installation Dolomite (Dolomite Microfluidics, Великобритания), Y-shaped polymer microfluidic chip with passive micromixer type "tesla coil", Nanosizer Zeta Pro nanoscale particle analyzer (LLC "Microtrack", Russia). Results and discussion. The study examined the effects of TFR and FRR parameters on LNF properties. Characteristics such as hydrodynamic diameter (Z-average), average particle diameter (D50), polydispersity index (PDI) and ζ potential were analyzed. The study confirms that with increasing FRR, the average hydrodynamic and median particle sizes decrease. Increasing TFR also decreases Z-average and D50 through hydrodynamic focusing, but at TFR = 3200 μl/min, particle size increases due to decreased nanoemulsion stability and fine particle aggregation. The study did not reveal a direct relationship between FRR and PDI. Nanoemulsions with FRRs of 1 : 3 and 1 : 4 showed the greatest homogeneity. As TFR increases, the polydispersity of the nanoparticles decreases. In the study, the dependence of the ζ potential of lipid nanoparticles on the estimated process parameters was not found. However, as TFR increases, the ζ potential tends to increase. Conclusion. In the study, the conditions for assembling lipid nanoparticles (LNP) using the microfluidic method were optimized. Mathematical models are proposed to control characteristics of nanoparticles. Optimal conditions for producing LNP: FRR = 1 : 3; 1 : 4; TFR 2000 to 3000 µL/min. If FRR = 1 : 5 and/or TFR > 3000 µL/min are used, the values may be outside the optimal range, which requires additional risk assessment.
- Open Access
- 20 June 2025
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
Experimental and CFD study of a new design of a direct-flow cyclone
Introduction. Purification of gas streams plays an important role in many industries in the field of environmental engineering. When implementing such measures, cyclones are often used – devices for cleaning gas streams from fine particles. In the pharmaceutical industry solving such problems requires the use of compact, highly efficient devices, for the development and study of which CFD-modelling methods have recently been increasingly used. The paper presents a comparison of the results of CFD-modelling of the gas purification process in a direct-flow cyclone of a new design and the capture efficiency in this apparatus obtained as a result of experimental studies.Aim. Comparison of the results of numerical modelling of the gas purification process in two configurations of a direct-flow cyclone of a new design with the experimental results.Materials and methods. The FlowVision software package was used for numerical CFD-modelling of the separation process in the studied device. The motion of the discrete phase – particles – was described using the Lagrangian particle model. Rosin-Rummler distribution with a minimum diameter of 15 microns, a median of 40 microns, and a maximum of 120 microns was used to distribute the particles by size. The experiments were carried out on an experimental setup, the main part of which was a direct-flow cyclone, a centrifugal fan and a screw doser. Technical talc was used as a model material, the dispersed particle distribution of which was determined by laser diffraction on a SALD-2300 particle analyzer (Shimadzu, Japan).Results and discussion. The CFD-model of the device allowed us to determine the gas velocity field, flow trajectories and particle capture efficiency in the studied configurations of a direct-flow cyclone. Based on the information about the gas velocity field and flow trajectories, conclusions were made about the most effective 4 design solutions. Comparison of the numerical simulation results and the experimental results showed good convergence.Conclusion. The developed design of the direct-flow cyclone showed good efficiency of fine particle capture. Numerical CFD-modelling allowed us to determine design features that negatively affect the efficiency and to optimize the design of the device. Good convergence of the model and experimental results confirms the possibility of using CFD-programmes for accurate modelling of technological processes and determining their parameters.
- 20 June 2025
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
Open AccessExperimental and CFD study of a new design of a direct-flow cyclone
Introduction. Purification of gas streams plays an important role in many industries in the field of environmental engineering. When implementing such measures, cyclones are often used – devices for cleaning gas streams from fine particles. In the pharmaceutical industry solving such problems requires the use of compact, highly efficient devices, for the development and study of which CFD-modelling methods have recently been increasingly used. The paper presents a comparison of the results of CFD-modelling of the gas purification process in a direct-flow cyclone of a new design and the capture efficiency in this apparatus obtained as a result of experimental studies.Aim. Comparison of the results of numerical modelling of the gas purification process in two configurations of a direct-flow cyclone of a new design with the experimental results.Materials and methods. The FlowVision software package was used for numerical CFD-modelling of the separation process in the studied device. The motion of the discrete phase – particles – was described using the Lagrangian particle model. Rosin-Rummler distribution with a minimum diameter of 15 microns, a median of 40 microns, and a maximum of 120 microns was used to distribute the particles by size. The experiments were carried out on an experimental setup, the main part of which was a direct-flow cyclone, a centrifugal fan and a screw doser. Technical talc was used as a model material, the dispersed particle distribution of which was determined by laser diffraction on a SALD-2300 particle analyzer (Shimadzu, Japan).Results and discussion. The CFD-model of the device allowed us to determine the gas velocity field, flow trajectories and particle capture efficiency in the studied configurations of a direct-flow cyclone. Based on the information about the gas velocity field and flow trajectories, conclusions were made about the most effective 4 design solutions. Comparison of the numerical simulation results and the experimental results showed good convergence.Conclusion. The developed design of the direct-flow cyclone showed good efficiency of fine particle capture. Numerical CFD-modelling allowed us to determine design features that negatively affect the efficiency and to optimize the design of the device. Good convergence of the model and experimental results confirms the possibility of using CFD-programmes for accurate modelling of technological processes and determining their parameters.
- Open Access
- 26 November 2024
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
Application of press-coatings for the development of prolonged release tablets based on hygroscopic substances
Introduction. The development of universal approaches to work with hygroscopic substances is an urgent task of pharmaceutical technology. Coating of tablets with hygroscopic substances deserves special attention. Pressed coatings represent a promising method for coating hygroscopic tablets. Such coating can contribute both to imparting the specified release characteristics to the tablet, and to the protection of APS from environmental factors, as well as can be an alternative to obtaining matrix tablets of prolonged action with hygroscopic substances in those cases when direct contact of APS with the polymeric carrier is undesirable.Aim. Study of the possibility of using pressed coatings to control the kinetics and release site of hygroscopic substances from tablets using DEAE as an example.Materials and methods. The object of the present study was the substance bis{2-[(2Z)-4-hydroxy-4-oxobut-2-enoyloxy]-N,N-diethylethanaminium} butanedioneate (DEAE), shellac (BonuLac®, Biogrund GmbH, Germany); copolymer of methacrylic acid and ethyl acrylate (AquaPolish® 712, Biogrund GmbH, Germany); copolymer of polyvinylpyrrolidone and polyvinyl acetate (Kollidon® SR, BASF, Germany), ethyl cellulose (Acros Organics, USA). Lactose monohydrate (Tablettose® 80, Meggle AG, Germany) was added to the formulations as an excipient. The superdisintegrant crospovidone XL and the lubricant sodium stearyl fumarate (JRS, Germany) were used to improve disintegration.Results and discussion. The properties of the pressed coatings were studied. Shellac-based coating mixture may be suitable for obtaining enteric soluble coating for dissolution in medium with pH 4.5. PVP and PVA copolymer does not provide stability of coatings in acidic medium, but its introduction into formulations with ethyl cellulose, as well as into formulations with copolymer of methacrylic acid and ethyl acrylate allows to achieve uniform release in all media within 5 hours.Conclusion. The study showed the possibility of using pressed coatings to control the kinetics of API release. The coating obtained using this technology can be used for hygroscopic substances. This method is a useful alternative when it is necessary to separate the matrix-forming polymer and the API, which have synergistic hygroscopic properties.
- 26 November 2024
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
Open AccessApplication of press-coatings for the development of prolonged release tablets based on hygroscopic substances
Introduction. The development of universal approaches to work with hygroscopic substances is an urgent task of pharmaceutical technology. Coating of tablets with hygroscopic substances deserves special attention. Pressed coatings represent a promising method for coating hygroscopic tablets. Such coating can contribute both to imparting the specified release characteristics to the tablet, and to the protection of APS from environmental factors, as well as can be an alternative to obtaining matrix tablets of prolonged action with hygroscopic substances in those cases when direct contact of APS with the polymeric carrier is undesirable.Aim. Study of the possibility of using pressed coatings to control the kinetics and release site of hygroscopic substances from tablets using DEAE as an example.Materials and methods. The object of the present study was the substance bis{2-[(2Z)-4-hydroxy-4-oxobut-2-enoyloxy]-N,N-diethylethanaminium} butanedioneate (DEAE), shellac (BonuLac®, Biogrund GmbH, Germany); copolymer of methacrylic acid and ethyl acrylate (AquaPolish® 712, Biogrund GmbH, Germany); copolymer of polyvinylpyrrolidone and polyvinyl acetate (Kollidon® SR, BASF, Germany), ethyl cellulose (Acros Organics, USA). Lactose monohydrate (Tablettose® 80, Meggle AG, Germany) was added to the formulations as an excipient. The superdisintegrant crospovidone XL and the lubricant sodium stearyl fumarate (JRS, Germany) were used to improve disintegration.Results and discussion. The properties of the pressed coatings were studied. Shellac-based coating mixture may be suitable for obtaining enteric soluble coating for dissolution in medium with pH 4.5. PVP and PVA copolymer does not provide stability of coatings in acidic medium, but its introduction into formulations with ethyl cellulose, as well as into formulations with copolymer of methacrylic acid and ethyl acrylate allows to achieve uniform release in all media within 5 hours.Conclusion. The study showed the possibility of using pressed coatings to control the kinetics of API release. The coating obtained using this technology can be used for hygroscopic substances. This method is a useful alternative when it is necessary to separate the matrix-forming polymer and the API, which have synergistic hygroscopic properties.
- Open Access
- 26 November 2024
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
Development of a topical formulation of a thiadiazole derivative
Introduction. Development of broad-spectrum antibacterial medicines for treatment of bacterial and fungal infections of animal skin is an urgent task of pharmaceutical industry, medicine and agricultural industry. The most promising dosage form for the treatment of superficial infectious diseases is gel. The most important advantages are the absence of side effects associated with ingestion, as well as the formation of a protective film that prevents re-infection of the animal.Aim. To develop the composition of topical form in the form of gel on the basis of active pharmaceutical substance with a wide spectrum of antimicrobial action for therapy of infectious diseases of animal skin.Materials and methods. The object of the study was an original substance – thiadiazole derivative, obtained by the organic synthesis department of the Department of Organic Chemistry of the Federal State Budgetary Educational Institution of Higher Professional Education SPHFU of the Ministry of Health of Russia. Gel formers (sodium alginate and carbomer), propylene glycol, surfactants (surfactants), etc. were used in the work. The obtained thiadiazole gels were studied in terms of pH, appearance, thermostability, colloidal stability, film formation, in addition, the rheological properties of the gels were determined.Results and discussion. It was found that gels in which sodium alginate and carbomer acted simultaneously as gel formers had thixotropic properties providing the best stability of the structure. The gels in which glycerin was added formed an elastic film preventing damage and drying of the animal skin.Conclusion. As a result of this study, a topical formulation in the form of a gel containing a new thiadiazole derivative was developed for the treatment of infectious diseases of animal skin.
- 26 November 2024
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
Open AccessDevelopment of a topical formulation of a thiadiazole derivative
Introduction. Development of broad-spectrum antibacterial medicines for treatment of bacterial and fungal infections of animal skin is an urgent task of pharmaceutical industry, medicine and agricultural industry. The most promising dosage form for the treatment of superficial infectious diseases is gel. The most important advantages are the absence of side effects associated with ingestion, as well as the formation of a protective film that prevents re-infection of the animal.Aim. To develop the composition of topical form in the form of gel on the basis of active pharmaceutical substance with a wide spectrum of antimicrobial action for therapy of infectious diseases of animal skin.Materials and methods. The object of the study was an original substance – thiadiazole derivative, obtained by the organic synthesis department of the Department of Organic Chemistry of the Federal State Budgetary Educational Institution of Higher Professional Education SPHFU of the Ministry of Health of Russia. Gel formers (sodium alginate and carbomer), propylene glycol, surfactants (surfactants), etc. were used in the work. The obtained thiadiazole gels were studied in terms of pH, appearance, thermostability, colloidal stability, film formation, in addition, the rheological properties of the gels were determined.Results and discussion. It was found that gels in which sodium alginate and carbomer acted simultaneously as gel formers had thixotropic properties providing the best stability of the structure. The gels in which glycerin was added formed an elastic film preventing damage and drying of the animal skin.Conclusion. As a result of this study, a topical formulation in the form of a gel containing a new thiadiazole derivative was developed for the treatment of infectious diseases of animal skin.
- Open Access
- 18 November 2024
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
Liposomes – metabolically active drug transport systems: visualization and pharmacokinetic. Part 2 (review)
Introduction. In the second part of the review we discussed aspects of visualization, pharmacokinetics and biodistribution of liposomes.Text. Many different methodsh as been proposed for the visualization of liposoms morphology and quality such as light microscopy, ESEM, TEM, AFM, etc. Each method have own advantages and limitations which are discussed in the article: In general, the selection of method depends on the specific morphological characteristics and level of details. It is important to understand the specificity of the liposomes and the visualization method for correct preparation of samples. Adequately performed pharmacokinetic and biodistribution studies can also be used as a tool for liposome visualization. The nature of active pharmaceutical ingredients, dose, lipid components, size of liposomes, charge, coating of liposomes with excipients and route of administration significantly affects the pharmacokinetics of liposomal forms. Additionally, the interaction of liposomal forms with the immune system, reticuloendothelial system and blood components play an important role in their absorption, distribution and elimination.Conclusion. The better understanding of the absorption, biodistribution, metabolism and clearance of liposomal formulations is essential for the development of modern drugs.
- 18 November 2024
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
Open AccessLiposomes – metabolically active drug transport systems: visualization and pharmacokinetic. Part 2 (review)
Introduction. In the second part of the review we discussed aspects of visualization, pharmacokinetics and biodistribution of liposomes.Text. Many different methodsh as been proposed for the visualization of liposoms morphology and quality such as light microscopy, ESEM, TEM, AFM, etc. Each method have own advantages and limitations which are discussed in the article: In general, the selection of method depends on the specific morphological characteristics and level of details. It is important to understand the specificity of the liposomes and the visualization method for correct preparation of samples. Adequately performed pharmacokinetic and biodistribution studies can also be used as a tool for liposome visualization. The nature of active pharmaceutical ingredients, dose, lipid components, size of liposomes, charge, coating of liposomes with excipients and route of administration significantly affects the pharmacokinetics of liposomal forms. Additionally, the interaction of liposomal forms with the immune system, reticuloendothelial system and blood components play an important role in their absorption, distribution and elimination.Conclusion. The better understanding of the absorption, biodistribution, metabolism and clearance of liposomal formulations is essential for the development of modern drugs.
- Open Access
- 1 November 2024
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
Production sustained release dosage forms from deliquescent substances by solid dispersion systems
Introduction. The production of solid dosage forms from hygroscopic substances is a complex technological task. The addition of hygroscopic substances into a polymer matrix allows to reduce their moisture absorption capacity.Aim. Reducing the hygroscopicity of deliquescent substances and obtaining sustained release solid dosage forms by using solid dispersion systems.Materials and methods. Substance: DEAE; excipients: Kollidon® VA 64, Soluplus®, PEG 1500, PEG 6000, PEG 8000, Poloxamer Kolliphor® P 188 and Kolliphor® P 407; reagents: hydrochloric acid, sodium dihydrogen phosphate, potassium hydrogen phosphate. The melt of the components was obtained on a twin-screw laboratory extruder and cast into silicone molds. The resulting solid dosage forms were studied for disintegration in three environments corresponding to the sections of the human gastrointestinal tract.Results and discussion. The active pharmaceutical substance DEAE is characterized as deliquescent substance. The introduction of DEAE into PEG-polymer matrices made it possible to reduce the hygroscopicity of solid dosage forms in the form of bars. The introduction of solubilizers into the melt made it possible to obtain bars with the appropriate organoleptic properties. The release of DEAE from bear- or toroid-shaped bars occurs on average 29–47 % faster than from heart-shaped bars.Conclusion. Compositions based on Soluplus® and Kolliphor® P 407 have proven promising for further development of tiles containing DEAE. In order to create tiles with a slow release, it is recommended to use heart-shaped forms, as they have a smaller surface area.
- 1 November 2024
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
Open AccessProduction sustained release dosage forms from deliquescent substances by solid dispersion systems
Introduction. The production of solid dosage forms from hygroscopic substances is a complex technological task. The addition of hygroscopic substances into a polymer matrix allows to reduce their moisture absorption capacity.Aim. Reducing the hygroscopicity of deliquescent substances and obtaining sustained release solid dosage forms by using solid dispersion systems.Materials and methods. Substance: DEAE; excipients: Kollidon® VA 64, Soluplus®, PEG 1500, PEG 6000, PEG 8000, Poloxamer Kolliphor® P 188 and Kolliphor® P 407; reagents: hydrochloric acid, sodium dihydrogen phosphate, potassium hydrogen phosphate. The melt of the components was obtained on a twin-screw laboratory extruder and cast into silicone molds. The resulting solid dosage forms were studied for disintegration in three environments corresponding to the sections of the human gastrointestinal tract.Results and discussion. The active pharmaceutical substance DEAE is characterized as deliquescent substance. The introduction of DEAE into PEG-polymer matrices made it possible to reduce the hygroscopicity of solid dosage forms in the form of bars. The introduction of solubilizers into the melt made it possible to obtain bars with the appropriate organoleptic properties. The release of DEAE from bear- or toroid-shaped bars occurs on average 29–47 % faster than from heart-shaped bars.Conclusion. Compositions based on Soluplus® and Kolliphor® P 407 have proven promising for further development of tiles containing DEAE. In order to create tiles with a slow release, it is recommended to use heart-shaped forms, as they have a smaller surface area.
- Open Access
- 25 October 2024
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
Liposomes – metabolically active drug transport systems: classification, components, preparation methods, and stabilization. Part 1 (review)
Introduction. This review article is focused on the modern classification of liposomes, preparation methods, stabilization and the role of structural components, visualization, and pharmacokinetics. Part 1 discusses the first three aspects mentioned above.Text. Depending on the size and number of bilayers, liposomes are classified into simple, long-circulating, cationic, immuno-liposomes, and sterically stabilized. The lipid components of liposomes can have a pronounced effect on target organs and tissues. Metabolites of the main components of liposomes have their biological activity, depending on their combination and dosage. All of the above indicates the promise of using liposomes not only as carriers of drugs but also as independent effectors that can have a significant impact on human metabolism in various diseases. The advantages and limitations of methods for preparing liposomes, and the features for manufacturing stealth liposomes are discussed. A special section of the article is dedicated to liposome stabilization.Conclusions. The information discussed in the review article may be useful in the development of pharmaceutical formulations in liposomes. Liposomes are not only promising nanocontainers for targeted drug delivery, but also metabolically active complexes with a wide spectrum of activity.
- 25 October 2024
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
Open AccessLiposomes – metabolically active drug transport systems: classification, components, preparation methods, and stabilization. Part 1 (review)
Introduction. This review article is focused on the modern classification of liposomes, preparation methods, stabilization and the role of structural components, visualization, and pharmacokinetics. Part 1 discusses the first three aspects mentioned above.Text. Depending on the size and number of bilayers, liposomes are classified into simple, long-circulating, cationic, immuno-liposomes, and sterically stabilized. The lipid components of liposomes can have a pronounced effect on target organs and tissues. Metabolites of the main components of liposomes have their biological activity, depending on their combination and dosage. All of the above indicates the promise of using liposomes not only as carriers of drugs but also as independent effectors that can have a significant impact on human metabolism in various diseases. The advantages and limitations of methods for preparing liposomes, and the features for manufacturing stealth liposomes are discussed. A special section of the article is dedicated to liposome stabilization.Conclusions. The information discussed in the review article may be useful in the development of pharmaceutical formulations in liposomes. Liposomes are not only promising nanocontainers for targeted drug delivery, but also metabolically active complexes with a wide spectrum of activity.
- Open Access
- 25 October 2024
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
Updating information of mycoses and antifungal medicines to find effective platforms for the production of new thiazole compounds
Introduction. Information about mycoses and antifungal drugs of the modern type is often fragmentary and unsystematic, which requires correction.Aim. To systematize the latest information about fungi and mycoses, means of combating them and the problems encountered along the way, to highlight the latest achievements in the field of synthesis and research of the activities of 1,2,4-triazole as a potential fungicidal compound.Materials and methods. The materials were the authors' research published in advanced scientific journals, conducted around the world in the field of studying fungi, antifungal drugs, and the search for new antifungal agents.Results and discussion. The article provides an overview of current information on the morphobiological features of fungi, updating their taxonomy and nomenclature, shows the role of fungi in nature and the development of fungal infections in humans and animals, structured information on the classification of mycoses and their pathogens. The latest information is also provided on the pharmacological properties of the main currently existing antifungal drugs, the mechanisms of formation of resistance to them in fungi, in a comparative aspect with other groups of antimycotic drugs, the prospects of azoles and their derivatives as new fungicidal drugs and disinfectants are shown. Literature studies have shown that 1,2,4-triazole derivatives have a wide range of antifungal activity, which extends to other types of activity.Conclusion. It was noted that the significant prospects of triazoles are due, among other things, to the fungicidal effect on resistant strains of fungi-pathogens of human and animal infections. The advantage of the new derivatives is the low level of concentrations suppressing fungi, low cytotoxicity, which allows them to be used for intravenous administration in the future. Updating information on the effectiveness of new antifungal compounds will help researchers systematize knowledge about the properties of azoles, which can contribute to the search and development of new potential candidates for antifungal drugs with high efficiency and selectivity, and contribute to the formation of new research directions for the search for effective means of combating mycoses in various fields of human activity.
- 25 October 2024
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
Open AccessUpdating information of mycoses and antifungal medicines to find effective platforms for the production of new thiazole compounds
Introduction. Information about mycoses and antifungal drugs of the modern type is often fragmentary and unsystematic, which requires correction.Aim. To systematize the latest information about fungi and mycoses, means of combating them and the problems encountered along the way, to highlight the latest achievements in the field of synthesis and research of the activities of 1,2,4-triazole as a potential fungicidal compound.Materials and methods. The materials were the authors' research published in advanced scientific journals, conducted around the world in the field of studying fungi, antifungal drugs, and the search for new antifungal agents.Results and discussion. The article provides an overview of current information on the morphobiological features of fungi, updating their taxonomy and nomenclature, shows the role of fungi in nature and the development of fungal infections in humans and animals, structured information on the classification of mycoses and their pathogens. The latest information is also provided on the pharmacological properties of the main currently existing antifungal drugs, the mechanisms of formation of resistance to them in fungi, in a comparative aspect with other groups of antimycotic drugs, the prospects of azoles and their derivatives as new fungicidal drugs and disinfectants are shown. Literature studies have shown that 1,2,4-triazole derivatives have a wide range of antifungal activity, which extends to other types of activity.Conclusion. It was noted that the significant prospects of triazoles are due, among other things, to the fungicidal effect on resistant strains of fungi-pathogens of human and animal infections. The advantage of the new derivatives is the low level of concentrations suppressing fungi, low cytotoxicity, which allows them to be used for intravenous administration in the future. Updating information on the effectiveness of new antifungal compounds will help researchers systematize knowledge about the properties of azoles, which can contribute to the search and development of new potential candidates for antifungal drugs with high efficiency and selectivity, and contribute to the formation of new research directions for the search for effective means of combating mycoses in various fields of human activity.